{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/31986354"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Nevertheless, significant concerns remain as to whether any of these first-generation myeloablative cancer-specific regimens are capable of achieving equipoise in a disease of low mortality such as MS, especially because the patients who are likely to benefit are generally not severely disabled." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "jamanetwork.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/124451442"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/31986354"] } } }
